FDA May Move on Plan B

This morning, the U.S. Food and Drug Administration (FDA) notified Barr Laboratories Inc., manufacturer of Plan B emergency contraception (EC), that it wanted to meet within seven days to discuss new steps the company must take to make Plan B available without a prescription to some women. The announcement comes one day before President Bush's nominee to lead the FDA, Dr. Andrew von Eschenbach, is scheduled to appear before a Senate committee, where he is expected to face tough questions on why a decision has not yet been made to make Plan B available without a prescription.